A 2023 preliminary report by Garel et al. in Neuropsychopharmacology examined the use of intravenous ketamine for benzodiazepine deprescription and withdrawal management in patients with treatment-resistant depression.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (1)

• treatment-resistant depression concept